A Randomized, Double-blind, Double-dummy, Parallel-group and Multicenter Study to Investigate Lurasidone in Treatment of Schizophrenia Compared With Risperidone
Phase of Trial: Phase III
Latest Information Update: 18 Nov 2019
Price : $35 *
At a glance
- Drugs Lurasidone (Primary) ; Risperidone
- Indications Schizophrenia
- Focus Therapeutic Use
- Sponsors Sumitomo Pharmaceuticals
- 26 Dec 2018 Status changed from recruiting to completed.
- 14 May 2014 Status changed from not yet recruiting to recruiting, as per Clinicaltrials.gov record.
- 11 Dec 2013 New trial record